Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,485	211.07	36.01	225.97	43.07	156.94
Short-Term Investments	-	0.16	0.15	40.15	0.06	8
Trading Asset Securities	-	-	-	-	-	150.21
Cash & Short-Term Investments	1,485	211.23	36.16	266.12	43.13	315.15
Cash Growth	-39.11%	484.23%	-86.41%	517.08%	-86.32%	-64.95%
Accounts Receivable	2,022	2,418	1,955	2,152	1,706	1,357
Other Receivables	10.73	31.38	48.07	1.58	0.01	0.71
Receivables	2,032	2,450	2,004	2,154	1,706	1,358
Inventory	3,062	3,264	2,642	2,287	1,727	1,529
Prepaid Expenses	-	22.78	22.18	37.91	71.18	25.66
Other Current Assets	464.59	2,126	3,203	265.17	429.94	2,271
Total Current Assets	7,047	8,074	7,908	5,010	3,976	5,499
Property, Plant & Equipment	7,355	6,964	6,360	6,192	5,931	6,775
Long-Term Investments	485.08	496.86	458.4	444.41	454.98	4.18
Other Intangible Assets	155.65	170.14	149.19	3.86	3.37	3.69
Other Long-Term Assets	2,178	1,174	663.79	601.97	739.28	91.01
Total Assets	17,220	16,879	15,539	12,252	11,106	12,373
Accounts Payable	1,489	2,221	2,296	1,744	1,677	1,100
Accrued Expenses	21.79	151.8	131.62	124.31	40.03	43.23
Short-Term Debt	472.04	426.03	140.48	1,410	228.41	28.43
Current Portion of Long-Term Debt	-	-	-	415.58	369.47	224
Current Portion of Leases	3.7	3.33	3.33	-	-	-
Other Current Liabilities	114.8	53.61	28.55	25.85	93.04	25.64
Total Current Liabilities	2,102	2,856	2,600	3,719	2,408	1,421
Long-Term Debt	2,340	1,316	1,204	1,488	2,082	4,275
Long-Term Leases	-	0.37	3.7	-	-	-
Pension & Post-Retirement Benefits	-	4.07	11.94	101.13	86.86	88.13
Long-Term Deferred Tax Liabilities	-	-	-	32.26	32.26	32.26
Other Long-Term Liabilities	39.96	29.8	24.4	24.89	23.27	27.26
Total Liabilities	4,482	4,206	3,844	5,366	4,632	5,843
Common Stock	507.19	507.19	507.19	408.16	408.16	408.16
Additional Paid-In Capital	-	8,465	8,465	4,645	4,645	4,645
Retained Earnings	-	-15,190	-16,180	-17,097	-17,558	-17,553
Comprehensive Income & Other	12,231	18,891	18,902	18,931	18,979	19,029
Shareholders' Equity	12,738	12,673	11,695	6,886	6,474	6,529
Total Liabilities & Equity	17,220	16,879	15,539	12,252	11,106	12,373
Total Debt	2,816	1,746	1,352	3,313	2,680	4,527
Net Cash (Debt)	-1,331	-1,535	-1,316	-3,047	-2,636	-4,212
Net Cash Per Share	-26.24	-30.26	-27.20	-74.66	-64.59	-103.20
Filing Date Shares Outstanding	50.65	50.72	50.72	40.82	40.82	40.82
Total Common Shares Outstanding	50.65	50.72	50.72	40.82	40.82	40.82
Working Capital	4,945	5,218	5,308	1,291	1,569	4,078
Book Value Per Share	251.49	249.86	230.58	168.72	158.61	159.96
Tangible Book Value	12,583	12,503	11,545	6,883	6,470	6,525
Tangible Book Value Per Share	248.42	246.51	227.64	168.62	158.53	159.87
Land	-	408.16	256.47	218.47	122.87	122.87
Buildings	-	1,865	1,849	1,783	1,439	1,439
Machinery	-	11,071	10,773	10,097	10,095	10,092
Construction In Progress	-	644.89	163.94	464.63	97.84	74.31

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.